Yechezkel Barenholz
Yechezkel Barenholz · Science & Medicine
Co-invented Doxil (PEGylated liposomal doxorubicin), the first FDA-approved nano-drug (1995), a widely used cancer chemotherapy.
April 27, 1941, Israel
Israel
Yechezkel Barenholz is recognized among Jewish contributors to Science & Medicine — Co-invented Doxil (PEGylated liposomal doxorubicin), the first FDA-approved nano-drug (1995), a widely used cancer chemotherapy.
Yechezkel 'Chezy' Barenholz is an Israeli professor of biochemistry at the Hebrew University of Jerusalem. Working in his field of liposome and membrane research, he co-invented Doxil (PEGylated liposomal doxorubicin), which in 1995 became the first FDA-approved nano-drug. Doxil remains a widely used cancer chemotherapy, delivering the drug more precisely to tumors while reducing side effects.
Verify and go deeper with these external references.
Source: Wikipedia
This page is published in seven languages from an English source. The translations are reviewed, but a mistake can still slip through. If you spot one on this profile — a wrong word, a lost date, a sentence that says something the English does not — please tell us.
Co-invented Doxil (PEGylated liposomal doxorubicin), the first FDA-approved nano-drug (1995), a widely used cancer chemotherapy.
Source: Wikipedia
